Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WS | N.MMED.WA | N.MMED.WR | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc > They get 1 share and one half share warrant for the $4.40

<< Previous

Bullboard Posts

Next >>

Comment by Silentbullon Dec 15, 2020 1:49pm

311 Views

Post# 32110210

RE:RE:RE:They get 1 share and one half share warrant for the $4.40

This volume is not sustainable, once it dries a daily slow bleed has to bring down the price, no doubts bout that. Some one asked about $3.75, all i say is price never goes up and down in a straight line, look at the chart in next 45-60 days and decide what was shared with you was correct or incorrect

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec